Erin J van Schaik

Dr. Erin J van Schaik

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
YZYong Zhang
Yong Zhang
JFJiaqi Fu
Jiaqi Fu
SLShuxin Liu
Shuxin Liu
LWLidong Wang
Lidong Wang
JQJiazhang Qiu
Jiazhang Qiu
ZLZhaoqing Luo
Zhaoqing Luo
Significance: Many effectors of the Coxiella burnetii Dot/Icm transporter are important for its virulence, but the lack of understanding of their biochemical activity prevents the use of them as potential therapeutic targets. Here, we found that the effector Cbu0513 (CinF) is a protein phosphatase that attacks IκBα, a key regulatory protein in NF-κB signaling. Unlike its homologs such as ST0318 from the archaeon Sulfolobus tokodaii , CinF has lost the enzymatic activity as a fructose-1,6-bisphosphate aldolase/phosphatase. Instead, it specifically targets IκBα to make it resistant to proteasome-mediated degradation in cells stimulated with NF-κB agonists. Our finding has expanded the strategy used by bacterial pathogens to inhibit host immunity, which may provide leads for the development of immune modulators for disease treatment.

1 March 2020 in Autophagy
Verified
Journal Article
Open access
FSFernande Ayenoue Siadous
Fernande Ayenoue Siadous
FCFranck Cantet
Franck Cantet
ESErin J van Schaik
Erin J van Schaik
MBMélanie Burette
Mélanie Burette
JAJulie Allombert
Julie Allombert
EMEric Martinez
Eric Martinez
Coxiella burnetii, the etiological agent of the zoonosis Q fever, replicates inside host cells within a large vacuole displaying autolysosomal characteristics. The development of this compartment is mediated by bacterial effectors, which interfere with a number of host membrane trafficking pathways. By screening a Coxiella transposon mutant library, we observed that transposon insertions in cbu0626 led to intracellular replication and vacuole biogenesis defects. Here, we demonstrate that CBU0626 is a novel member of the Coxiella vacuolar protein (Cvp) family of effector proteins, which is translocated by the Dot/Icm secretion system and localizes to vesicles with autolysosomal features as well as Coxiella-containing vacuoles (CCVs). We thus renamed this effector CvpF for Coxiella vacuolar protein F. CvpF specifically interacts with the host small GTPase RAB26, leading to the recruitment of the autophagosomal marker MAP1LC3B/LC3B (microtubule associated protein 1 light chain 3 beta) to CCVs. Importantly, cvpF::Tn mutants were highly attenuated compared to wild-type bacteria in the SCID mouse model of infection, highlighting the importance of CvpF for Coxiella virulence. These results suggest that CvpF manipulates endosomal trafficking and macroautophagy/autophagy induction for optimal C. burnetii vacuole biogenesis. Abbreviations: ACCM: acidified citrate cystein medium; AP: adaptor related protein complex; CCV: Coxiella-containing vacuole; Cvp: Coxiella vacuolar protein; GDI: guanosine nucleotide dissociation inhibitor; GDF: GDI dissociation factor; GEF: guanine exchange factor; LAMP1: lysosomal associated membrane protein 1; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MTORC1: mechanistic target of rapamycin kinase MTOR complex 1; PBS: phosphate-buffered saline; PMA: phorbol myristate acetate; SQSTM1/p62: sequestosome 1; WT: wild-type.

1 December 2019 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
AGA. E. Gregory
A. E. Gregory
ESErin J van Schaik
Erin J van Schaik
KRKasi Russell-Lodrigue
Kasi Russell-Lodrigue
AFA. P. Fratzke
A. P. Fratzke
James SamuelJames Samuel
James Samuel
Coxiella burnetii, the etiological agent of Q fever, is a Gram-negative bacterium transmitted to humans by inhalation of contaminated aerosols. Acute Q fever is often self-limiting, presenting as a febrile illness that can result in atypical pneumonia. In some cases, Q fever becomes chronic, leading to endocarditis that can be life threatening. The formalin-inactivated whole-cell vaccine (WCV) confers long-term protection but has significant side effects when administered to presensitized individuals.

1 April 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
JYJing Yang
Jing Yang
MEMohammed Eslami
Mohammed Eslami
YCYi-Pei Chen
Yi-Pei Chen
MDMayukh Das
Mayukh Das
DZDongmei Zhang
Dongmei Zhang
PFPaul De Figueiredo
Paul De Figueiredo
Significance: Assessing the threat posed by bacterial samples is fundamentally important to safeguarding human health. Whole-genome sequence analysis of bacteria provides a route to achieving this goal. However, this approach is fundamentally constrained by the scope, the diversity, and our understanding of the bacterial genome sequences that are available for devising threat assessment schemes. For example, genome-based strategies offer limited utility for assessing the threat associated with pathogens that exploit novel virulence mechanisms or are recently emergent. To address these limitations, we developed PathEngine, a machine learning strategy that features the use of phenotypic hallmarks of pathogenesis to assess pathogenic threat. PathEngine successfully classified potential pathogenic threats with high accuracy and thereby establishes a phenotype-based, sequence-independent pipeline for threat assessment.

20 April 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
ABAnna Olivia Busbee
Anna Olivia Busbee
AAAryashree Arunima
Aryashree Arunima
James SamuelJames Samuel
James Samuel
ESErin J van Schaik
Erin J van Schaik
C. burnetii (Cb) is an obligate intracellular bacterial pathogen that replicates within alveolar macrophages following aerosol infection. Unlike most intracellular bacteria, Cb establishes a lysosome-derived replicative niche (Coxiella-containing vacuole or CCV) through the action of its Type IVB secretion system (T4BSS). This system translocates a large repertoire of effector proteins into the host cytoplasm after phagosome acidification. These effectors interfere with diverse signaling pathways to co-opt host processes, such as vesicle trafficking, ubiquitylation, gene expression and lipid metabolism, promoting pathogen survival without triggering robust proinflammatory signaling or host cell death pathways. This effector-triggered immune silencing is particularly unique given the central role of macrophages as innate immune sentinels. In this review, we examine Cb T4BSS effectors that have been characterized as central determinants of innate immunity modulation. We discuss innate immune sensing pathways potentially engaged during infection, including Toll-like receptors, NOD-like receptors, RIG-I-like receptors, inflammasomes, and interferon signaling pathways, and highlight evidence indicating that these pathways are actively suppressed. Emphasis is placed on effector-mediated regulation of NF-κB signaling, type I interferon responses, and inflammasome activation. Finally, we address unresolved questions related to effector-triggered immunity, redundancy in immune suppression, and discrepancies between in vitro and in vivo infection models.

24 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
SMSaugata Mahapatra
Saugata Mahapatra
AAAryashree Arunima
Aryashree Arunima
ABAnna Busbee
Anna Busbee
JDJennifer E. Dumaine
Jennifer E. Dumaine
LSLauren Stranahan
Lauren Stranahan
James SamuelJames Samuel
James Samuel
Coxiella burnetii (Cb), the causative agent of Q fever, replicates within host macrophages by modulating innate immune responses through its type IVB secretion system (T4SS). Host cells sense pathogens via Pattern recognition receptors (PRRs), including Toll-like receptors (TLRs), to recognize pathogen-associated molecular patterns (PAMPs) and initiate signaling pathways that drive pro-inflammatory cytokine and interferon responses. Toll-like receptor 3 (TLR3) triggers the nuclear translocation of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and Interferon regulatory factors (IRFs) resulting in pro-inflammatory cytokine production and type I interferon (IFN-I) induction. Here we demonstrate that Cb requires T4SS to suppress TLR3-induced NF-κB and IRF transcriptional responses. Furthermore, RNA purified from both virulent and avirulent Cb is sufficient to activate TLR3, identifying pathogen RNA as a relevant PAMP in this context. Using a pulmonary infection model with virulent Cb, we found that TLR3/ Toll-Interleukin-1 Receptor Domain-Containing Adapter Protein Inducing Interferon Beta (TRIF)-dependent innate immune pathway inhibits cachexia. In contrast, signaling through the interferon-α/β receptor (IFNAR) restricts bacterial dissemination, indicating that these pathways play distinct but complementary roles in host defense. Mechanistically, Cb suppresses TLR3/TRIF signaling in a T4SS-dependent manner by preventing host TLR3 recruitment to the Coxiella-containing vacuole (CCV) and disrupting TRIF–TNF Receptor-Associated Factor 6 (TRAF6) interactions, thereby selectively inhibiting impairing NF-κB activation. Consistent with this, we identify five T4SS effector proteins that attenuate TLR3-induced NF-κB signaling, including CBU1292, which suppresses both NF-κB and IRF-dependent responses downstream of TLR3. Author summary: Pathogenic bacteria have evolved mechanisms to evade or manipulate host immune defenses. Coxiella burnetii (Cb), the causative agent of Q fever, replicates within immune cells and interferes with innate immune signaling pathways. We found that its type IVB secretion system (T4SS) express effectors that inhibit immune responses triggered by Toll-like receptor 3 (TLR3), a sensor that detects microbial RNA. Specifically, Cb suppresses signaling through the adaptor protein TRIF, thereby reducing activation of key immune regulators, NF-κB and interferon regulatory factors (IRFs), which are required for inflammatory and antiviral responses. Using a mouse model of lung infection, we found that disruption of TLR3/TRIF signaling and type I interferon receptor (IFNAR) signaling leads to different disease outcomes, indicating that these pathways play distinct roles in controlling infection and disease severity. We also identified several Cb-secreted effectors that interfere with TLR3-mediated immune activation, including one that inhibits both NF-κB and interferon responses. Together, our findings reveal how Cb evades immune detection by targeting a critical RNA-sensing pathway and highlight distinct host defense mechanisms that limit bacterial infection and disease.